Treatment satisfaction instruments for different purposes during a product's lifecycle: Keeping the end in mind

Patient

Volumn 4, Issue 4, 2011, Pages 227-240

  Rofail, Diana ^a   Taylor, Fiona ^a   Regnault, Antoine ^b   Filonenko, Anna ^c  

^a ADELPHI REAL WORLD   (United Kingdom)

^b MAPI VALUES   (United States)

^c BAYER PHARMA AG   (Germany)

Author keywords

Formularies; Outcome assessment (health care); Patient preference; Research and development.

Indexed keywords

CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; EMBASE; HEALTH CARE PLANNING; HUMAN; INFORMATION PROCESSING; INSTRUMENT VALIDATION; MARKET; MEDLINE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PRODUCT PARAMETERS; PRODUCT SAFETY; PSYCINFO; QUALITY CONTROL; QUESTIONNAIRE; REVIEW; SATISFACTION; TREATMENT RESPONSE;

HUMANS; PATIENT SATISFACTION; QUESTIONNAIRES; RESEARCH DESIGN;

EID: 80054121018     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/11595280-000000000-00000     Document Type: Review

References (64)

1. Sitzia J, Wood N. Patient satisfaction: a review of issues and concepts. Soc Sci Med 1997 Dec; 45 (12): 1829-43 (Pubitemid 27525984)
2. Pascoe GC. Patient satisfaction in primary health care: a literature review and analysis. Eval Program Plann 1983; 6 (3-4): 185-210
3. Rofail D, Gray R, Gournay K. The development and internal consistency of the satisfaction with Antipsychotic Medication Scale. Psychol Med 2005 Jul; 35 (7): 1063-72 (Pubitemid 41015704)
4. Rofail D, Regnault A, Baladi J-F, et al. Assessing treatment satisfaction during a product's lifecycle to facilitate market access: definitions, frameworks, and measurement. ISPOR Connections 2010; 16 (3): 7-10
5. Fayers P, Hays R. Assessing quality of life in clinical trials: methods and practice. Oxford: Oxford University Press, 2005
6. Atkinson M, Kumar R, Cappelleri J, et al. Hierarchical construct validity of the treatment satisfaction questionnaire for medication TSQMversion II among outpatient pharmacy consumers. Value Health 2005 Nov; 8: S9-24 (Pubitemid 43110282)
7. Atkinson M, Sinha A, Hass S, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004 Feb 26; 2: 12
8. Weaver M, Patrick DL, Markson LE, et al. Issues in the measurement of satisfaction with treatment. Am J Manag Care 1997 Apr; 3 (4): 579-94 (Pubitemid 127528785)
9. Rofail D, Abetz L, Viala M, et al. Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed patient instrument. Value Health 2009 Jan; 12 (1): 109-17
10. Rejas J, Monfort J, Campillo M, et al. Criterion validity of the ARthritis Treatment Satisfaction (ARTS) questionnaire: patient satisfaction with treatment and need for switching therapy. Clin Drug Invest 2009; 29 (8): 527-38
11. Martin M, Patrick D, Bushnell D, et al. Development of the asthma treatment satisfaction measure. Curr Med Res Opin 2009; 25 (10): 2495-506
12. Kozma C, Slaton T, Monz B, et al. Development and validation of a patient satisfaction and preference questionnaire for inhalation devices. Treat Resp Med 2005; 4 (1): 41-52 (Pubitemid 40360818)
13. Mathias SD, Warren EH, Colwell HH, et al. A new treatment satisfaction measure for asthmatics: a validation study. Qual Life Res 2000; 9 (7): 873-82 (Pubitemid 32209802)
14. Campbell JL, Kiebert GM, Partridge MR. Development of the satisfaction with inhaled asthma treatment questionnaire. Eur Res Journal 2003 Jul; 22 (1): 127-34 (Pubitemid 36896482)
15. Black L, Grove A, Morrill B. The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms. Health Qual Life Outcomes 2009; 7: 55
16. Coyne K, Joshua G, Kimel M, et al. Validation of the treatment satisfaction questionnaire for Crohn's disease TSQ-C. Digestive Diseases and Sciences 2005; 50 (2): 252-8 (Pubitemid 40311528)
17. Anderson R, Girman C, Pawaskar M, et al. Diabetes medication satisfaction tool. Diabetes Care 2009; 32 (1): 51-3
18. Donatti C, Wild D, Horblyuk R, et al. Psychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale SOADAS. Diab Res Clin Prac 2008; 80 (1): 108-13
19. Anderson RT, Skovlund SE,Marrero D, et al. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther 2004; 26 (4): 565-78 (Pubitemid 38586458)
20. Cappelleri JC, Gerber RA, Kourides IA, et al. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care 2000; 23 (12): 1799-803
21. Gillham R, Bryant C, Kane K. Validation of the side effect and life satisfaction SEALS inventory. Seizure 2000 Oct; 9 (7): 458-63
22. Dibenedetti D, Gondek K, Sagnier P, et al. The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. Eur Urol 2005; 48 (3): 503-11 (Pubitemid 41188412)
23. Kubin M, Trudeau E, Gondek K, et al. Early conceptual and linguistic development of a patient and partner treatment satisfaction scale TSS for erectile dysfunction. Eur Urol 2004; 46 (6): 768-74 (Pubitemid 39488410)
24. Shikiar R, Flood E, Siddique R, et al. Development and validation of the Gastroesophageal Reflux Disease Treatment SatisfactionQuestionnaire.DigDis Sci 2005; 50 (11): 2025-33 (Pubitemid 41504084)
25. RuizM, Pardo A, Rejas J, et al. Development and validation of the Treatment Satisfaction with Medicines Questionnaire SATMED-Q. Value Health 2008; 11 (5): 913-26
26. Bharmal M, Payne K, Atkinson M, et al. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication TSQM-9 among patients on antihypertensive medications. Health Qual Life Outcomes 2009; 7: 36
27. Ruiz MA, Pardo A, Martinez de la Casa JM, et al. Development of a specific questionnaire measuring patient satisfaction with glaucoma treatment: Glausat. Ophthalmic Epidemiol 2010; 17 (3): 131-43
28. Hill CD, Fehnel SE, Bobula JD, et al. Development and preliminary validation of the Menopause Symptoms Treatment Satisfaction Questionnaire MS-TSQ. Menopause 2007; 14 (6): 1047-55 (Pubitemid 350098665)
29. Revicki D, Kimel M, Beusterien K, et al. Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment. Headache 2006; 46 (2): 240-52
30. Patrick DL, Martin ML, Bushnell DM, et al. Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratings. Clin Ther 2003; 25 (11): 2920-35 (Pubitemid 37510601)
31. Abetz L, Coombs JH, Keininger DL, et al. Development of the cancer therapy satisfaction questionnaire: item generation and content validity testing. Value Health 2005; 8 Suppl. 1: S41-53 (Pubitemid 43110285)
32. Flood EM, Beusterien KM, Green H, et al. Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q TM ), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women. Health Qual Life Outcomes 2006 Jul 11; 4: 42
33. Piault E, Evans C, Espindle D, et al. Development and validation of the Overactive Bladder Satisfaction OAB-S questionnaire. Neurourol Urodyn 2008; 27 (3): 179-90 (Pubitemid 351399306)
34. Evans C, Trudeau E, Mertzanis P, et al. Development and validation of the Pain Treatment Satisfaction Scale PTSS: a patient satisfaction questionnaire for use in patients with chronic or acute pain. Pain 2004; 112 (3): 254-66 (Pubitemid 39550725)
35. Baró E, Casado A, GarcÆa C, et al. Assessing satisfaction with pain medication in primary care patients: development and psychometric validation of a new measure. Clin Ther 2004; 26 (7): 1124-36
36. Vernon M, Revicki D, Awad A, et al. Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients. Schiz Res 2010 May; 118 (1-3): 271-8
37. Bech P, Moses R, Gomis RN. The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy nai've type 2 diabetes: a placebo-controlled, multicentre study. Qual Life Res 2003 Jun; 12 (4): 413-25 (Pubitemid 36609886)
38. Brod M, Cobden D, Lammert M, et al. Examining correlatesof treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health Qual Life Outcomes 2007; 5: 8
39. Best JH, Boye KS, Rubin RR, et al. Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily. Diab Med 2009 Jul; 26 (7): 722-8
40. GharabawiG,Greenspan A, Rupnow M, et al. Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial. BMS Psych 2006; 6: 45
41. Renzi C, Picardi A, Abeni D, et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Derm 2002Mar; 138 (3): 337-42 (Pubitemid 34226331)
42. Weiss K, Paramore L, Liljas B, et al. Patient satisfaction with budesonide turbuhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler in a managed care setting. J Asthma 2005 Nov; 42 (9): 769-76 (Pubitemid 41759193)
43. Massiou H, Pradalier A, Donnet A, et al. Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. Eur Neurol 2006; 55 (4): 198-203
44. Perimenis P, Roumeguere T, Heidler H, et al. Evaluation of patient expectations and treatment satisfaction after 1-year tadalafil therapy for erectile dysfunction: the DETECT study. J Sex Med 2009 Jan; 6 (1): 257-67
45. Newman LC, Cady RK, Landy S, et al. Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan. Int J Clin Prac 2008 Dec; 62 (12): 1889-99
46. Gasquet I, Tcherny L, Lépine J, et al. Patient satisfaction with psychotropic drugs: sensitivity to change and relationship to clinical status, quality-of-life, compliance and effectiveness of treatment: results from a nation-wide 6-month prospective study. Eur Psych 2006 Dec; 21 (8): 531-8
47. Landy S, DeRossett S, Rapoport A, et al. Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes. MedGenMed 2007; 9 (2): 53
48. Biderman A, Noff E, Harris S, et al. Treatment satisfaction of diabetic patients: what are the contributing factors? Fam Prac 2009 Apr; 26 (2): 102-8
49. Markson LE, Vollmer WM, Fitterman L, et al. Insight into patient dissatisfaction with asthma treatment. Arch Int Med 2001 Feb 12; 161 (3): 379-84 (Pubitemid 32116553)
50. Pollack M, Purayidathil F, Bolge S, et al. Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and healthrelated quality of life. Diabetes Res Clin Pract 2010 Feb; 87 (2): 204-10
51. Nett RB, Tiseo PJ, Almas M, et al. Patient satisfaction with eletriptan in the acute treatment of migraine in primary care. Int J Clin Prac 2007 Oct; 61 (10): 1677-85 (Pubitemid 47404392)
52. Coons SJ, Rao S, Keininger DL, et al. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000 Jan; 17 (1): 13-35 (Pubitemid 30072853)
53. Rofail D, Abetz L, Gater A, Brown C. The significance of patient-reported outcomes to facilitate market accessduring a product's lifecycle. ISPOR 11th Annual European Congress; 2008 Nov 8-11; Athens
54. Novak A, de la Loge C, Abetz L, et al. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception 2003 Mar; 67 (3): 187-94 (Pubitemid 36255655)
55. Novak A, Abetz L, de la Loge C. Validation of vaginal contraception acceptability questionnaire. ISPOR 4th Annual European Congress; 2001 Nov 11-13; Cannes
56. NHS. London New Drugs Group. APC/DTC briefing document. London: NHS, 2008
57. Novak A, de la Loge C, Abetz L. Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing. Pharmacoeconomics 2004; 22 (4): 245-56 (Pubitemid 38393393)
58. Coulter A. Do patients want a choice and does it work? BMJ 2010; 341: c4989
59. Secretary of State for Health. Equity and excellence: liberatin the NHS. London: Stationery Office, 2010 60 Bertini L, Tagariello V, Mancini S, et al. 075% and 05% ropivacaine for axillary brachial plexus block: a clinical comparison with 05% bupivacaine. Reg Anesth Pain Med 1999 Nov; 24 (6): 514-8
60. Rawal N, Allvin R, Axelsson K, et al. Patient-controlled regional analgesia (PCRA) at home: controlled comparison between bupivacaine and ropivacaine brachial plexus analgesia. Anesthesiology 2002 Jun; 96 (6): 1290-6 (Pubitemid 34587194)
61. Dubois D, Gilet H, Viala-Danten M, et al. Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation. Neurogastroenterol Motil 2010 Feb; 22 (2): e54-63
62. EMEA. Committee for medicinal products for human use summary of positive opinion for Resolor. International Nonproprietary Name (INN): prucalopride. 23-7-2009 London: EMEA, 2010
63. Arnould B. Patient-reported outcomes and clinical practice. From measurement instruments to decision tools: much more than a simple change in format. PRO Newsletter 2006; 36: 21-4
64. Cole M, McLean V. Therapeutic relationships re-defined. Occ Ther Men Health 2003; 19: 33-56 (Pubitemid 37315027)